MYC and cancer: Focusing on the TCGA pan-cancer study, which includes data from 33 cancer types (Table 1), we first observed the CNV and mutational profiles of the tumor suppressor RB1, the proto-oncogene MYC, and the translation initiation factor EIF4E (Figure 1a).